EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

Cost‐Effectiveness of Venom Immunotherapy in Preventing Severe Bee and Wasp Sting Reactions

Gunter Sturm iD, Maria Beatrice Bilò iD, Carmen Vidal iD, Joanna N G Oude Elberink iD, Jochen Schmitt iD, Andreas Kallsoy Slættanes, Thilo Jakob iD

Allergy · 2026

DOI: 10.1111/all.70176 ↗

At a glance

Journal article in Allergy, 2026. Written by Gunter Sturm and 6 co-authors. Institution: Department of Dermatology and Venereology, Medical University of Graz, Graz, Austria. Major MEDLINE topics: Insect Bites and Stings, Desensitization, Immunologic, Wasp Venoms, Bee Venoms. Cited 4 times so far (Crossref); 42 references. The full text is freely available (open access, CC BY 4.0). Funded by: ALK-Abelló.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background

Systemic sting reactions (SSRs) from bee and wasp stings can cause severe symptoms, including anaphylaxis and potentially lead to fatal outcomes. These reactions can significantly affect individuals' daily lives due to the fear and anxiety associated with the risk of stings. Venom immunotherapy (VIT) has been shown to be an effective preventive treatment for SSRs, offering a viable alternative to emergency treatments like adrenaline auto‐injectors (AAIs).

Methods

We created a decision tree framework with a Danish payer perspective designed to evaluate the cost‐effectiveness of VIT with Alutard ® SQ in individuals with bee and/or wasp venom allergies. Input in the model was identified from a structured literature review and expert consensus. The incremental cost‐effectiveness ratio (ICER) of Hymenoptera venom depot immunotherapy (HVDI) compared to AAIs over a 10‐year time horizon was estimated. The impact of uncertainty associated with key assumptions was investigated using univariate deterministic sensitivity analyses (DSA).

Results

In the base case, the incremental cost of HVDI was €7428, while the incremental quality‐adjusted life years (QALYs) gained were 0.48. Consequently, the ICER (cost per QALY) of HVDI compared to AAIs after 10 years was estimated at €15,550.

Conclusion

VIT is a cost‐effective treatment for the prevention of severe reactions to wasp and/or bee stings when compared to AAIs.

Subjects

MeSH terms (MEDLINE)

Insect Bites and StingsDesensitization, ImmunologicWasp VenomsBee VenomsAnaphylaxisCost-Benefit AnalysisHumansAnimalsBeesWaspsQuality-Adjusted Life Years

Author keywords

immunotherapy vaccines and mechanismsquality of lifevenom and insect allergy

Substances

Wasp VenomsBee Venoms

Authors and institutions

  • Department of Dermatology and Venereology, Medical University of Graz, Graz, Austria.
  • Allergy Outpatient Clinic Reumannplatz, Vienna, Austria.
  • Department of Clinical and Molecular Sciences, Università Politecnica Delle Marche, Ancona, Italy.
  • Allergy Unit, Department of Internal Medicine, University Hospital Ospedali Riuniti di Ancona, Ancona, Italy.
  • Allergy Department, Complejo Hospitalario Universitario de Santiago, Faculty of Medicine USC, Santiago de Compostela, Spain.
  • Department of Allergology, University Medical Center Groningen, University of Groningen, and Groningen Research Institute for Asthma and COPD, Groningen, the Netherlands.

ORCID profiles: Gunter Sturm, Maria Beatrice Bilò, Carmen Vidal, Joanna N G Oude Elberink, Jochen Schmitt, Thilo Jakob

Funding

  • ALK-Abelló

Cite

APA

Sturm, G., Bilò, M. B., Vidal, C., Oude Elberink, J. N. G., Schmitt, J., Slættanes, A. K., & Jakob, T. (2026). Cost‐Effectiveness of Venom Immunotherapy in Preventing Severe Bee and Wasp Sting Reactions. Allergy. https://doi.org/10.1111/all.70176

Vancouver

Sturm G, Bilò MB, Vidal C, Oude Elberink JNG, Schmitt J, Slættanes AK, et al. Cost‐Effectiveness of Venom Immunotherapy in Preventing Severe Bee and Wasp Sting Reactions. Allergy. 2026. doi:10.1111/all.70176

BibTeX
@article{Sturm2026,
  author = {Sturm, Gunter and Bilò, Maria Beatrice and Vidal, Carmen and Oude Elberink, Joanna N G and Schmitt, Jochen and Slættanes, Andreas Kallsoy and Jakob, Thilo},
  title = {Cost‐Effectiveness of Venom Immunotherapy in Preventing Severe Bee and Wasp Sting Reactions},
  journal = {Allergy},
  year = {2026},
  doi = {10.1111/all.70176}
}
Start for free →